We found a higher expression level of IFNG and immune checkpoint genes in the CIN-Low group versus CIN-High group (Supplementary Figure S4C and Figures 7B–D), which suggested that CIN-Low patients had possibility to benefit from ICB. The gene discussed is IFNG; the disease is cervical squamous intraepithelial neoplasia.